Study details
Enrolling now
Anxiety During Abstinence in Alcohol Use Disorder
Columbia University
NCT IDNCT06793488ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
60
Study length
about 4 years
Ages
21–55
Locations
1 site in NY
About this study
This trial is testing how anxiety changes during abstinence in people with alcohol use disorder (AUD). Researchers will give some participants disulfiram to help them stay abstinent and scan their brains using fMRI. They are also comparing this to healthy volunteers who do not receive disulfiram.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Disulfiram 250 mg
- 2.Undergo functional MRI
PhaseEARLY_Phase 1
DrugDisulfiram 250 mg
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
disulfiram
Drug routes
oral (Oral Tablet)
Procedures
imaging
Body systems
Psychiatry / Mental Health